EUVIMEDEUVIMED entdecken
Open Access

Endometriosis Typology and Ovarian Cancer Risk

Mollie E Barnard, Leslie V Farland, Bin Yan, Jing Wang, Britton Trabert, Jennifer A Doherty, Huong D Meeks, Myke Madsen, Emily Guinto, Lindsay J Collin, Kathryn A Maurer, Jessica M Page und 7 weitere

JAMA · 13.08.2024 · 332 (6) · 482

DOI: 10.1001/jama.2024.9210 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 13.08.2024. Verfasst von Mollie E Barnard und 18 weiteren Autor:innen. Beteiligte Einrichtung: Huntsman Cancer Institute, University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Endometriosis, Ovarian Neoplasms. Die Arbeit wurde bisher 179-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CDC HHS, NCRR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Endometriosis has been associated with an increased risk of ovarian cancer; however, the associations between endometriosis subtypes and ovarian cancer histotypes have not been well-described.

Objective

To evaluate the associations of endometriosis subtypes with incidence of ovarian cancer, both overall and by histotype. Design, Setting, and Participants Population-based cohort study using data from the Utah Population Database. The cohort was assembled by matching 78 893 women with endometriosis in a 1:5 ratio to women without endometriosis. Exposures Endometriosis cases were identified via electronic health records and categorized as superficial endometriosis, ovarian endometriomas, deep infiltrating endometriosis, or other. Main Outcomes and Measures Estimated adjusted hazard ratios (aHRs), adjusted risk differences (aRDs) per 10 000 women, and 95% CIs for overall ovarian cancer, type I ovarian cancer, and type II ovarian cancer comparing women with each type of endometriosis with women without endometriosis. Models accounted for sociodemographic factors, reproductive history, and past gynecologic operations.

Results

In this Utah-based cohort, the mean (SD) age at first endometriosis diagnosis was 36 (10) years. There were 597 women with ovarian cancer. Ovarian cancer risk was higher among women with endometriosis compared with women without endometriosis (aHR, 4.20 [95% CI, 3.59-4.91]; aRD, 9.90 [95% CI, 7.22-12.57]), and risk of type I ovarian cancer was especially high (aHR, 7.48 [95% CI, 5.80-9.65]; aRD, 7.53 [95% CI, 5.46-9.61]). Ovarian cancer risk was highest in women with deep infiltrating endometriosis and/or ovarian endometriomas for all ovarian cancers (aHR, 9.66 [95% CI, 7.77-12.00]; aRD, 26.71 [95% CI, 20.01-33.41]), type I ovarian cancer (aHR, 18.96 [95% CI, 13.78-26.08]; aRD, 19.57 [95% CI, 13.80-25.35]), and type II ovarian cancer (aHR, 3.72 [95% CI, 2.31-5.98]; aRD, 2.42 [95% CI, −0.01 to 4.85]). Conclusions and Relevance Ovarian cancer risk was markedly increased among women with ovarian endometriomas and/or deep infiltrating endometriosis. This population may benefit from counseling regarding ovarian cancer risk and prevention and could be an important population for targeted screening and prevention studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisOvarian NeoplasmsAdultAgedFemaleHumansMiddle AgedYoung AdultCohort StudiesIncidenceProportional Hazards ModelsRisk FactorsUtahRetrospective StudiesOvary

Autor:innen und Institutionen

  • Huntsman Cancer Institute, University of Utah, Salt Lake City.
  • Department of Population Health Sciences, University of Utah, Salt Lake City.
  • Slone Epidemiology Center, Boston University Chobanian & Avedisian School of Medicine, Boston, Massachusetts.
  • Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, and Department of Obstetrics and Gynecology, College of Medicine-Tucson, University of Arizona, Tucson.
  • Department of Family and Preventive Medicine, University of Utah Health, Salt Lake City.
  • Department of Obstetrics and Gynecology, University of Utah, Salt Lake City.

Förderung

  • CDC HHS
  • NCRR NIH HHS
  • NCI NIH HHS

Zitieren

APA

Barnard, M. E., Farland, L. V., Yan, B., Wang, J., Trabert, B., Doherty, J. A., Meeks, H. D., Madsen, M., Guinto, E., Collin, L. J., Maurer, K. A., Page, J. M., Kiser, A. C., Varner, M. W., Allen-Brady, K., Pollack, A. Z., Peterson, K. R., Peterson, C. M., & Schliep, K. C. (2024). Endometriosis Typology and Ovarian Cancer Risk. JAMA, 332(6), 482. https://doi.org/10.1001/jama.2024.9210

Vancouver

Barnard ME, Farland LV, Yan B, Wang J, Trabert B, Doherty JA, et al. Endometriosis Typology and Ovarian Cancer Risk. JAMA. 2024;332(6):482. doi:10.1001/jama.2024.9210

BibTeX
@article{Barnard2024,
  author = {Barnard, Mollie E and Farland, Leslie V and Yan, Bin and Wang, Jing and Trabert, Britton and Doherty, Jennifer A and Meeks, Huong D and Madsen, Myke and Guinto, Emily and Collin, Lindsay J and Maurer, Kathryn A and Page, Jessica M and Kiser, Amber C and Varner, Michael W and Allen-Brady, Kristina and Pollack, Anna Z and Peterson, Kurt R and Peterson, C Matthew and Schliep, Karen C},
  title = {Endometriosis Typology and Ovarian Cancer Risk},
  journal = {JAMA},
  year = {2024},
  volume = {332},
  number = {6},
  pages = {482},
  doi = {10.1001/jama.2024.9210}
}
Kostenlos starten →